You didn’t ask for this. You don’t want to deal with insurance companies, mounting medical bills, and a lengthy recovery. You just want to get your life back on track as quickly as you can.
If you suffer from diabetes, you know that unmanaged blood sugar can lead to serious complications. What you may not know is that the medication you take to manage your blood sugar levels could increase your risk of a life-threatening complication called diabetic ketoacidosis.
Hundreds of patients suffering from DKA have already sued because they think their condition is a result of taking Invokana. You can, too. If you took Invokana and developed DKA, the drug could be to blame.
We know what you are going through right now. You’re confused, angry, and scared to learn that the drug you took to make you better may have put your life at risk. You’re still trying to manage your diabetes, figure out your treatment options, and pay your medical bills. You don’t understand the complex rules that apply to drug safety and warnings. And you are dealing with all of this because a rich drug company put profits before safety.
The Connection Between Invokana And Diabetic Ketoacidosis
Even before they approved Invokana for sale, the Food and Drug Administration (FDA) raised concerns about, potentially serious side effects.” According to The New York Times, the advisory council that approved the medication also voiced these concerns. Their fears proved valid. In the years that followed, the FDA received hundreds of complaints of serious side effects. You can read about some of them at the Institute for Safe Medication Practices.
In May 2015, the FDA first warned that Invokana might lead to DKA. The FDA based that warning on 20 reports of DKA it received between March 2013 and June 6, 2014. All 20 patients required hospitalization and/or emergency room treatment. These reports raised a red flag at the FDA because people with type 2 diabetes usually don’t get DKA.
Since this warning, the number of reported DKA cases continued to rise. In fact, some doctors think that the number of DKA cases may be higher than reported. Many patients diagnosed with DKA actually had blood sugar levels below what doctors expected to see. Doctors didn’t immediately diagnose the condition correctly, which delayed treatment.
In December 2015, the FDA required Invokana and other SGLT2 inhibitor drugs to include new warnings about the risk of DKA. It also warned patients to stop taking these drugs and get immediate medical help if they noticed any DKA symptoms.
As of May 2017, the FDA had received more than 2500 reports of DKA linked to Invokana and similar drugs. This included 37 DKA deaths, according to an August 2017 scientific article published in Diabetologia.
Invokana Diabetic Ketoacidosis Lawsuits And Settlements
According to the company’s most recent annual report, there are more than 1,100 lawsuits. This number will only increase as more victims come forward.
On December 7, 2016, the United States Judicial Panel on Multidistrict Litigation ordered federal Invokana cases consolidated in multidistrict litigation (MDL) No. 2750 (PDF) in the federal district court for the District of New Jersey before Judge Brian R. Martinotti. As of February 15, 2018, the MDL included 985 ongoing cases. The MDL cases are in pretrial discovery. The first trial will begin on September 2018.
According to Johnson & Johnson, there are also Invokana lawsuits pending in state courts in Pennsylvania, California, and New Jersey.
Invokana Diabetic Ketoacidosis Lawsuits In The News
The latest news from the Invokana MDL is that the bellwether trials will begin on September 2018. Bellwethers are test cases the parties select to go to trial first. The parties use the test trials to get an idea of how the other cases might play out. The bellwether trials will likely determine if, when, and how settlement negotiations proceed.